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Extracellular matrix (ECM) components, such as chondroitin sulfate (CS) and tricalcium 
phosphate, serve as raw materials, and thus spatial patterning of these raw materials 
may be leveraged to mimic the smooth transition of physical, chemical, and mechanical 
properties at the bone-cartilage interface. We hypothesized that encapsulation of oppos-
ing gradients of these raw materials in high molecular weight poly(d,l-lactic-co-glycolic 
acid) (PLGA) microsphere-based scaffolds would enhance differentiation of rat bone 
marrow–derived stromal cells. The raw material encapsulation altered the microstructure 
of the microspheres and also influenced the cellular morphology that depended on the 
type of material encapsulated. Moreover, the mechanical properties of the raw material 
encapsulating microsphere-based scaffolds initially relied on the composition of the scaf-
folds and later on were primarily governed by the degradation of the polymer phase and 
newly synthesized ECM by the seeded cells. Furthermore, raw materials had a mitogenic 
effect on the seeded cells and led to increased glycosaminoglycan (GAG), collagen, and 
calcium content. Interestingly, the initial effects of raw material encapsulation on a per-cell 
basis might have been overshadowed by medium-regulated environment that appeared 
to favor osteogenesis. However, it is to be noted that in vivo, differentiation of the cells 
would be governed by the surrounding native environment. Thus, the results of this study 
demonstrated the potential of the raw materials in facilitating neo-tissue synthesis in 
microsphere-based scaffolds and perhaps in combination with bioactive signals, these 
raw materials may be able to achieve intricate cell differentiation profiles required for 
regenerating the osteochondral interface.
Keywords: raw materials, chondroitin sulfate, tricalcium phosphate, gradient, microsphere-based scaffolds
introduction
A scaffold with opposing gradients of physical and chemical signals at the osteochondral interface 
may trigger simultaneous bone and cartilage regeneration by having a cooperative effect on tissue 
regeneration. Our previous studies have shown that 3D microsphere-based gradient scaffolds have 
the potential to guide the chondro- and osteogenic differentiation of cells in different regions of the 
scaffolds. Moreover, the gradients in signals have the ability to control patterning of cell phenotype and 
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to secrete tissue-specific extracellular matrix (ECM) components 
to promote osteochondral interface regeneration (Dormer et al., 
2010, 2011, 2012b; Mohan et al., 2011).
Chondroitin sulfate (CS), a glycosaminoglycan (GAG) and 
a key ECM component of cartilage, when incorporated into 3D 
scaffolds resulted in increased DNA, GAG, and collagen accumula-
tion by the cultured cells (Uygun et al., 2009; Kim et al., 2014). 
Moreover, CS also enhanced their chondrogenic gene expression 
(Chen et al., 2013). Likewise, bioactive ceramic beta-tricalcium 
phosphate (β-TCP) is widely used in bone tissue engineering 
because of its excellent oseteoconductivity, cellular adhesion, 
mechanical properties, and faster degradation rate than other 
crystalline calcium phosphates. Scaffolds incorporating β-TCP 
have shown better potential for osteogenic differentiation than 
the scaffolds without it (Takahashi et al., 2005; Liao et al., 2013; 
Todo and Arahira, 2013). We have previously demonstrated that 
encapsulation of raw materials, such as CS and bioactive glass (BG 
possesses the capability to directly bind to bone), in low molecular 
weight (around 40–45  kDa) poly(D,L-lactic-co-glycolic acid) 
(PLGA) microsphere-based scaffolds created a favorable environ-
ment for cells to create a tissue-specific ECM. Additionally, evident 
regional variation in newly synthesized ECM indicated that the 
raw materials could potentially be used to replace growth factors, 
thus holding tremendous clinical significance by providing a more 
streamlined path for regulatory approval and greater financial 
incentive for translation to the clinic (Mohan et al., 2013).
The low molecular weight PLGA microsphere-based scaffolds 
are well suited for in vitro studies as signal release and cellular 
response to the encapsulated signals can be conveniently studied 
in these scaffolds because of rapid degradation of microspheres 
(Tracy, 1999; Alexis, 2004; Singh et al., 2008; Dormer et al., 2010, 
2012a; Mohan et al., 2013). Moreover, these low molecular weight 
scaffolds can also be used to study tissue regeneration in small 
animal model in vivo studies where skeletal changes occur at a 
faster rate compared to humans (Pearce et al., 2007; Mohan et al., 
2011; Dormer et al., 2012b). In order for a scaffold to be clini-
cally effective and commercially successful, it is imperative that 
its biodegradation rate matches with the tissue regeneration rate 
in animal models that closely approximate the human regenera-
tion rate. To begin exploring the clinical implications of our raw 
material microsphere gradient scaffolds, we need to translate our 
successes with scaffolds in  vitro and in  vivo with small animal 
models to scaffolds that can be employed in preclinical animal 
models. The foremost step in that direction will be to study cel-
lular response toward encapsulated factors released from a scaffold 
system that can be employed in translational animal models (such 
as sheep, dogs, etc.). Therefore, the objective of this study was 
to investigate the in  vitro response of raw material encapsulat-
ing microsphere-based scaffolds fabricated with high molecular 
weight PLGA as a first step to establish the clinical efficacy of 
these scaffolds. PLGA with an intrinsic viscosity (i.v.) of ~0.7 (MW: 
106–112 kDa) was chosen for this study due to its relevance in 
large animal studies (Fonseca et al., 2014), and to correspond to 
an ongoing sheep study from our group. The polymer formula-
tion used in the study represents a more translational product, 
inspired by a Coulter Foundation-funded project and input from 
Food and Drug Administration (FDA) regulatory consultant and 
business advisors. From this study, we hope to gain an insight into 
parameters that can have profound implications during in vivo 
experiments.
In this study, we investigated whether the encapsulated raw 
materials (CS and TCP) in high molecular weight PLGA scaf-
folds can provide building blocks and facilitate differentiation 
of the seeded cells simultaneously in the direction of bone- and 
cartilage-like cells. 3D microsphere-based scaffolds were fabricated 
using high molecular weight PLGA microspheres encapsulating 
CS (for cartilage regeneration) and TCP (for bone regeneration) 
as raw materials. Additionally, scaffolds containing gradient of the 
raw materials were also fabricated via a gradient technology as 
previously reported (Singh et al., 2008). The response of rat bone 
marrow-derived stromal cells (rBMSCs) to the raw materials was 
evaluated when cultured in a medium consisting of exogenous fac-
tors. We hypothesized that encapsulation of raw materials, CS and 
TCP, in high molecular weight PLGA microsphere-based scaffolds 
would enhance the differentiation of rBMSCs toward chondro-
genic and osteogenic lineages, respectively. Moreover, we anticipate 
rBMSCs in gradient scaffolds to differentiate simultaneously along 
an osteochondral route as previously seen in low molecular weight 
scaffolds encapsulating CS and BG (Mohan et al., 2013).
Materials and Methods
Materials
Poly(d,l-lactic-co-glycolic acid) (50:50, lauryl ester end group, 
MW =  106  kDa) with an i.v. of 0.65  dL/g (“PLGA50:50”), and 
PLGA (75:25, lauryl ester end group, MW =  112  kDa) with an 
i.v. of 0.69 dL/g (“PLGA75:25”) were obtained from Lakeshore 
Biomaterials (Birmingham, AL, USA). Murine IGF-I was obtained 
from Peprotech, Inc. (Rocky Hill, NJ, USA). Chondroitin-4-sulfate 
(lyophilized powder of CS, a sodium salt from bovine trachea) and 
TCP powder (<200 nm particle) were obtained from Sigma (St. 
Louis, MO, USA). All other reagents and organic solvents utilized 
were of cell culture or ACS grade.
Fabrication of Microspheres
Three different types of microspheres were fabricated for the study: 
(i) PLGA75:25 microspheres (PLGA), (ii) CS–NaHCO3 encapsu-
lated PLGA50:50 microspheres (CS), and (iii) TCP-encapsulated 
PLGA75:25 microspheres (TCP). The rationale for choosing PLGA 
with two different compositions was to correspond to an on going 
in vivo sheep study from our group. The relatively faster degrading 
polymer (PLGA50:50) was selected for its ability to release the raw 
materials quickly in the cartilage region to facilitate chondrogen-
esis, whereas the slower degrading polymer (PLGA75:25) in the 
bone region was selected to lend more structural stability to the 
regenerating tissue. The CS–NaHCO3 encapsulated microspheres 
were fabricated by adding 2% w/v CS and 2% w/v NaHCO3 to 
16% w/v PLGA50:50 dissolved in dichloromethane (DCM), and 
the TCP encapsulated microspheres were fabricated by adding 
4% w/v TCP to 16% w/v PLGA75:25 dissolved in DCM. Using 
the PLGA-CS/TCP emulsions, microspheres were fabricated via 
our previously reported technology (Berkland et al., 2001; Singh 
et al., 2008; Dormer et al., 2010, 2011, 2012a,b; Mohan et al., 2011, 
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2013). Briefly, using acoustic excitation produced by an ultrasonic 
transducer (Branson Ultrasonics, Danbury, CT, USA), regular jet 
instabilities were created in the polymer stream, thereby creating 
uniform polymer droplets. An annular carrier non-solvent stream 
of 0.5% w/v poly (vinyl alcohol) (PVA, 88% hydrolyzed, 25 kDa, 
Polysciences, Inc., Warrington, PA, USA) in deionized water (DI 
H2O) surrounding the polymer droplets was flowed using a coaxial 
nozzle that carried the emanated polymer droplets into a beaker 
containing the non-solvent solution at 0.5% w/v in DI H2O, to 
prevent aggregation of the droplets. The polymer droplets were 
stirred for 3–4 h to allow for solvent to evaporate, and then filtered 
and rinsed with DI H2O to remove residual PVA, and stored at 
-20°C. The particles were lyophilized for 48 h before further use.
scaffold Fabrication
Gradient scaffolds (“GRADIENT” group) were prepared using our 
previously established technology (Singh et al., 2008; Dormer et al., 
2010; Mohan et al., 2011, 2013). In brief, lyophilized microspheres 
(50–100 mg) of two different types, CS and TCP, were dispersed 
in DI H2O and loaded into two separate syringes. The suspensions 
were then pumped at opposing flow rates using programmable 
syringe pumps (PHD 22/2000; Harvard Apparatus, Inc., Holliston, 
MA, USA) into a cylindrical plastic mold (diameter ~ 4 mm) having 
a filter at the bottom until a height of about 6 mm was reached. 
The scaffolds were 3.8–4.0 mm in diameter and around 6 mm in 
height. The profile for these gradient constructs was linear, where 
the top one-fourth of the total height comprised of CS microspheres 
(1.5 mm), then the next one-fourth (1.5 mm) was a linear transition 
from CS to TCP microspheres, and the remaining half (3 mm) 
contained only TCP microspheres. The stacked microspheres were 
then sintered with ethanol-acetone (95:5 v/v) for 55 min. The scaf-
folds were further lyophilized for 48 h and sterilized with ethylene 
oxide for 12 h prior to cell seeding experiments. The control PLGA 
and other homogenous scaffolds, abbreviated as CS and TCP, were 
fabricated by packing the corresponding microspheres into the 
same molds, followed by sintering for 55 min, except for PLGA 
scaffolds (sintered for 45 min). The homogeneous scaffolds had 
dimensions similar to GRADIENT scaffolds (diameter 3.8–4.0 mm 
and height 6  mm). A total of four different groups were tested 
in the study and were named according to the composition of 
microspheres as: PLGA, CS, TCP, and GRADIENT.
cell seeding of scaffolds
Rat bone marrow-derived stromal cells were obtained from 
the femurs of 10 young male Sprague–Dawley rats (176–200 g, 
SASCO), following a University of Kansas approved IACUC 
protocol (175–08) and cultured in medium consisting of α-MEM 
supplemented with 10% FBS (MSC-Qualified, cat #10437-028) 
and 1% penicillin–streptomycin (P/S) (all from Invitrogen Life 
Technologies, Carlsbad, CA, USA). When the cells were 80–90% 
confluent, they were trypsinized and re-plated at 7,000 cells/cm2. 
Seeding was performed when cells reached P4. Scaffolds were steri-
lized using ethylene oxide for 12 h, allowed to ventilate overnight 
after sterilization, and placed in a 24-well plate. Cells (P4) were resus-
pended in culture medium at a concentration of ~10 million/mL. 
Eighty microliters of this cell suspension (~750  K cells) were 
placed directly onto the top of the scaffold, which infiltrated the 
scaffold via capillary action (Dormer et  al., 2012a). Cells were 
allowed to attach for 1 h after which 2 mL of culture medium was 
added. After 24 h, the culture medium was replaced by 2 mL of 
differentiation medium consisting of α-MEM, 1% P/S, 10% FBS, 
4 mM β-glycerophosphate (β-GP), 100 nM dexamethasone (DEX) 
(MP Biomedicals, Santa Ana, CA, USA), 25 mM HEPES buffer 
(Fisher Scientific, Fairlawn, NJ, USA), and 100  ng/mL murine 
IGF-I (Peprotech Inc., Rocky Hill, NJ, USA). Every 48  h for 
6 weeks, two-thirds of the differentiation medium were replaced 
with fresh medium.
scanning electron Microscopy
Scaffolds in culture were fixed in glutaraldehyde followed by 
dehydration in ethanol. Afterwards, the scaffolds were lyophilized 
for 48 h prior to imaging. The PLGA, CS, TCP, and GRADIENT 
acellular (week 0) and cellular (week 1.5) microsphere-based 
scaffolds were imaged using a LEO 1550 field emission scanning 
electron microscope at an accelerating voltage of 10 kV.
Mechanical Testing
Unconfined compression tests of the acellular (week 0) and cellular 
(week 6) microsphere-based scaffolds (n = 4–5) were conducted 
using a uniaxial testing apparatus (Instron Model 5848, Canton, 
MA, USA) with a 50 N load cell. A custom-made stainless steel bath 
and compression-plate assembly were mounted in the apparatus 
(Singh, 2008). Cylindrical scaffold samples were compressed to 
80% strain at a strain rate of 1%/s under phosphate-buffered saline 
[PBS: 0.138M sodium chloride, 0.0027M potassium chloride] at 
37°C. Among all possible testing modalities, compression at a 
1%/s strain rate provides the most valuable information in terms 
of achieving high strain levels to view the entire stress-strain 
profile, which cyclic testing and stress relaxation/creep testing do 
not provide, and moreover a reproducible elastic modulus can 
be obtained without preconditioning as we have done in the past 
(Detamore and Athanasiou, 2003). Compressive moduli of elastic-
ity were calculated from the initial linear regions, ~5% strain, of 
the stress–strain curves as described previously (Singh et al., 2008; 
Dormer et al., 2010, 2012a; Mohan et al., 2013).
Porosity Measurement
We have previously demonstrated a close match between theo-
retical porosities and porosities measured by porosimetry and 
microCT (Singh et al., 2008; Jeon et al., 2013). Therefore, a fluid 
saturation method was used in this study to calculate the porosities 
of the scaffolds:
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where VB, m, d, h, WW, WD, and VP are the bulk volume, mass, 
diameter, height, wet weight, dry weight, and pore volume of the 
scaffolds, respectively. WWater and ρWater are the weight and density of 
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water. Briefly, wet and dry weights of scaffolds were recorded after 
fabrication and porosities were determined by the above-described 
method.
Biochemical analyses
Engineered constructs (n = 5) were analyzed for matrix production 
at 0, 3, and 6 weeks. The samples were digested in two different 
types of digestion solution: (i) Papain solution for DNA, GAG, 
and hydroxyproline (HYP) content analyses, and (ii) Triton-X 
solution for calcium content and alkaline phosphatase (ALP) activ-
ity analyses. The papain digestion solution consisted of 125 mg/
mL papain (from papaya latex), 5 mM N-acetyl cysteine, 5 mM 
ethylenediaminetetraacetic acid, and 100 mM potassium phosphate 
buffer (20 mM monobasic potassium phosphate, 79 mM dibasic 
potassium phosphate) (all reagents from Sigma Aldrich) in DI H2O. 
Engineered constructs were removed from culture in a sterile man-
ner, placed in microcentrifuge tubes, homogenized with the papain 
solution (1 mL), and allowed to digest overnight in a 60°C water 
bath. The digested scaffolds were then centrifuged at 10,000 rpm 
for 5 min to pellet fragments of polymer and other impurities and 
stored at -20°C. Later, the supernatant was used to determine DNA, 
GAG, and HYP contents using the Picogreen (Molecular Probes, 
Eugene, OR, USA), dimethylmethylene blue (DMMB) (Biocolor, 
Newtownabbey, Northern Ireland), and HYP (cat #MAK008, Sigma 
Aldrich, St. Louis, MO, USA) assays, respectively. For calcium and 
ALP analyses, constructs were digested in 0.05% Triton X-100 and the 
supernatants were placed in the -20°C before the analyses. Calcium 
content was assessed using a QuantiChromTM Calcium Assay Kit 
(DICA-500; QuantiChrom, Hayward, CA, USA). ALP activity was 
estimated by determining liberated p-nitrophenol (p-NITRO) rate 
(concentration/μg DNA per minute) as described elsewhere (Boyan 
et al., 1989). In the cases of GAG and calcium content, the values of 
acellular controls for CS and TCP groups (listed in Tables S1 and S2 
in Supplementary Material), respectively, were subtracted from the 
corresponding values of the cellular scaffolds at each time point in 
an effort to distinguish the bioactivity provided by the CS and TCP 
from the amounts retained in the scaffolds.
gene expression analyses
Reverse transcriptase quantitative polymerase chain reaction 
(RT-qPCR) was performed for gene expression analyses in micro-
sphere-based constructs (n = 3–5) at weeks 0, 1.5, 3, and 6. Certain 
groups at certain time points (indicated in Section “Results”) had 
insufficient sample size (n < 3) because some of the samples were 
lost during processing. In preparation for RT-qPCR, samples were 
first homogenized in 1 mL of Trizol reagent (Invitrogen), and the 
RNA was isolated according to the manufacturer’s guidelines. 
Isolated RNA was cleaned using an RNeasy spin column method 
(Qiagen, Valencia, CA, USA) and converted to complementary 
DNA using a TaqMan High Capacity kit (Applied Biosystems, 
Foster City, CA, USA) in an Eppendorf Realplex Mastercycler. 
TaqMan Gene expression assays from Applied Biosystems for 
appropriate genes (Table 1) were run in the Eppendorf system. A 
2-ΔΔCt method was used to evaluate the relative level of expression 
for each target gene. For quantification, the PLGA constructs 
at week 0 were designated as the calibrator group and GAPDH 
expression as the endogenous control.
TaBle 1 | genes used for rT-qPcr analysis.
gene symbol TaqMan assay iD
Glyceraldehyde 3-phosphate dehydrogenase GAPDH Rn01775763_g1
SRY (sex determining region Y)-box 9 SOX9 Rn01751069_mH
Collagen type II COL2A1 Rn01751069_mH
Aggrecan ACAN Rn00573424_m1
Collagen type I COL1A1 Rn01463848_m1
Runt-related transcription factor 2 RUNX2 Rn01512298_m1
Bone gamma-carboxyglutamate protein BGLAP Rn00566386_g1
Secreted phosphoprotein 1 SPP1 Rn01449972_m1
Integrin-binding sialoprotein IBSP Rn00561414_m1
statistical analyses
SPSS 21.0 (IBM, Armonk, NY, USA) was used for constructing 
standard box plots for outlier elimination. For statistical inference 
in Sections “Mechanical Testing” and “Porosity Measurement”, a 
single factor analysis of variance (ANOVA) was performed with 
SPSS, followed by a Tukey’s honestly significant difference post hoc 
test when significance was detected below the p = 0.05 value. In 
Sections “Biochemical Analyses” and “Gene Expression Analyses”, 
the statistical inference was performed using a two-factor ANOVA 
followed by a Tukey’s honestly significant difference post hoc test 
when significance was detected below the p =  0.05 value. The 
model included the two factors (scaffold type and time) and 
the possible interactions between them. All quantitative results 
(numerical values and representative diagrams) are expressed as 
the average ± SD.
results
scanning electron Microscopy
Figures 1 and 2 represent the scanning electron micrographs of all 
four types of scaffolds. Figure 1 demonstrates that the fabricated 
microspheres were uniform in size (Figure S1 in Supplementary 
Material) and also illustrates the overall porous nature of micro-
sphere-based scaffolds with interconnected pores. Additionally, it 
highlights the differences in microsphere morphology among the 
various scaffold groups. The microspheres in PLGA-only scaffolds 
(Figure 1A) were smooth with surface film layers being formed 
as a result of plasticization of PLGA with ethanol-acetone (Singh 
et  al., 2008). The microspheres in CS scaffolds (Figures  1B,D) 
had minute pores on their surface while the microspheres in 
TCP scaffolds had a rougher appearance (Figures  1C,E) than 
microspheres in the PLGA-only group. The GRADIENT scaffold 
image (Figure 1F) shows fusion between porous (CS) and rough 
(TCP) microspheres at the transition region of the scaffold. Apart 
from the differences in microsphere structure, variations were also 
observed in the cellular morphology of the cell-seeded constructs 
(Figure 2). At Day 10 (week 1.5), very few cells were observed in 
the PLGA-only scaffolds residing in pores between the adjacent 
microspheres, and these cells possessed a rounded morphology 
(Figure 2A). By contrast, a far greater number of cells could be 
seen in the other three groups with differences appearing in the 
cellular morphologies. Cells covered the surface of the micro-
spheres almost completely in the CS scaffolds and appeared to 
be flat with cell–cell connections being evident at the sintering 
junctions between the adjacent microspheres (Figure 2B). Cells 
Figure 2 | cellular morphology of rBMscs at day 10 (week 1.5) on different scaffold groups: (a) Plga, (B) cs, (c) TcP, and (D) graDienT as 
depicted by the scanning electron micrographs. Scale bar: 100 μm.
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in the TCP scaffolds had a round appearance, and were clustered 
around the microsphere sintering junctions (Figure 2C). Both cell 
types with round (in clusters) and flat morphologies were present 
in the GRADIENT group (Figure  2D). However, no apparent 
morphological differences were observed in cells from distinct 
regions of the GRADIENT scaffold.
Figure 1 | scanning electron micrographs of acellular microsphere-based scaffolds. The images reveal the distinct morphological features of the microspheres 
in different scaffold groups: (a) PLGA, (B,D) CS, (c,e) TCP, and (F) GRADIENT at the CS (white arrow)-TCP (blue arrow) transition region. Scale bar: 100 μm.
Mechanical Testing
Tricalcium phosphate acellular scaffolds had an average elastic 
modulus of 194 ± 16 kPa at week 0 that was 4- (p < 0.05), 4.8- 
(p <  0.05), and 2.8-fold (p <  0.05) higher than the moduli of 
PLGA, CS, and GRADIENT scaffolds, respectively (Figure 3A). 
Additionally, among the cell-seeded scaffolds, TCP constructs at 
Figure 4 | Total Dna content as measured in the microsphere-based 
scaffolds over weeks 0, 3, and 6. All values are expressed as the 
average ± SD (n = 3–5), p < 0.05. @Statistically significant change over week 
0 value, #statistically significant change over its value at previous time point, 
*statistically significant change over the PLGA group at same time point, and 
$statistically significant change over the TCP and GRADIENT groups at same 
time point.
TaBle 2 | average porosities of different scaffold groups.
group average Porosity (%)
PLGA 21.0 ± 6.8
CS 49.6 ± 4.4*
TCP 21.6 ± 6.8
GRADIENT 18.4 ± 4.6
*Statistically significantly higher than the other three groups.
Figure 3 | elastic modulus. (a) Acellular constructs at week 0. (B) Cellular 
constructs at week 6. All values are expressed as the average ± SD 
(n = 3–5), p < 0.05 *Statistically significant change over the other three 
groups, %statistically significant change over the CS group. PLGA constructs 
at week 6 are not shown in the figure.
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week 6 had an average modulus of 0.84 ± 0.55 MPa that was 208.8-
fold (p < 0.05) higher than the modulus of the CS group (Figure 3B). 
Surprisingly, it was observed that the PLGA constructs at week 6 
had an average modulus of 11.4 ± 6.6 MPa (not shown in the figure) 
that was orders of magnitude higher than the moduli of the other 
three groups at that time. No significant differences were observed 
between the elastic moduli of CS and GRADIENT groups at week 6.
Porosity Measurement
The average porosity of CS group was 49.6 ± 4.4% that was 2.4-fold 
(p < 0.05) higher than the porosity of the PLGA group (Table 2). 
Moreover, the porosities of the scaffolds in the CS group were 
also statistically significantly higher than the porosities of their 
counterparts in the TCP and GRADIENT groups. No significant 
differences in porosities were observed among any other groups.
Biochemical analysis
DNA Content
The DNA content results (Figure  4) revealed no significant 
differences in the amount of DNA present in the four distinct 
types of scaffolds at weeks 0 and 3. At week 6, the DNA content 
in CS scaffolds was 31.7-fold (p <  0.05) higher than the DNA 
content in the PLGA group. The TCP and GRADIENT groups also 
outperformed the PLGA control at week 6, with 15- (p < 0.05) and 
18-fold (p < 0.05) higher DNA contents, respectively. Moreover, 
the DNA content in the CS group at week 6 was statistically signifi-
cantly higher than the DNA contents in the TCP and GRADIENT 
groups at that time. Additionally, the CS, TCP, and GRADIENT 
groups were observed to have statistically significantly higher DNA 
content at week 6 than their corresponding values at weeks 0 and 
3; however, no significant differences in the DNA content over 
time were observed in the PLGA group.
GAG Content
A trend similar to DNA content was observed in the GAG content 
(Figure  5A), where no significant differences appeared among 
groups at weeks 0 and 3. At week 6, the net GAG content of the 
CS scaffolds was 5.5-fold (p < 0.05) higher than the GAG content 
of the PLGA group. Moreover, the GAG content in the CS group 
at week 6 was also statistically significantly higher than the GAG 
contents in the TCP and GRADIENT groups. No significant dif-
ferences in the GAG content were observed among the other three 
groups week 6, meaning that the CS group was the only group to 
statistically significantly outperform the PLGA control at that time. 
The GAG content in the CS scaffolds (22.2 ± 7.5 μg) at week 6 was 
found to be statistically significantly higher than its corresponding 
Figure 5 | gag content as measured in the microsphere-based 
scaffolds over weeks 0, 3, and 6. GAG content in the acellular constructs 
(CS and GRADIENT groups) was subtracted from the GAG content in the 
corresponding cellular constructs. (a) Total GAG content in micrograms per 
construct. (B) Normalized GAG content in micrograms per micrograms DNA. 
All values are expressed as the average ± SD (n = 3–5), p < 0.05. 
@Statistically significant change over week 0 value, #statistically significant 
change over its value at previous time point, *statistically significant change 
over the PLGA group at same time point, $statistically significant change over 
the TCP and GRADIENT groups at same time point, and &statistically 
significant change over the TCP group at same time point.
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values at weeks 0 and 3. The TCP and the GRADIENT groups had 
significantly higher GAG content at week 6 than their respective 
values at week 0. Furthermore, the PLGA and TCP groups at week 
3 had significantly higher GAG content when it was normalized to 
the DNA content than the normalized GAG content of the CS and 
GRADIENT groups at that time (Figure 5B). However, at week 
6, only the TCP group statistically significantly differed from the 
PLGA group in the normalized GAG content. It must be noted that 
the values of GAG content obtained from the biochemical analysis 
represent both the GAGs present in the ECM secreted by the cells 
and the CS released by the scaffold and then entrapped within the 
ECM. The values do not represent the CS left entrapped within 
the polymer matrix, as the GAG content of acellular controls was 
subtracted at each time point.
HYP Content
At week 0, only the GRADIENT group outperformed the PLGA 
group in HYP content with 2.6-fold (p < 0.05) higher HYP content 
(Figure 6A). Moreover, the HYP content in the GRADIENT group 
at week 0 was statistically significantly higher than the HYP contents 
in the CS and TCP groups. Week 3 HYP content results showed that 
the CS and GRADIENT groups had 1.9- (p < 0.05) and 2.9-fold 
higher HYP content than the PLGA group, respectively. Also, the 
GRADIENT group at week 3 had statistically significantly higher 
HYP content than the CS and TCP groups. At week 6, both the 
CS and the GRADIENT groups outperformed the PLGA control, 
with HYP contents that were 2.2- (p < 0.05) and 2.1-fold (p < 0.05) 
higher, respectively. Additionally, the CS and GRADIENT groups 
had statistically significant higher HYP contents than the TCP 
group at week 6. The CS and GRADIENT groups were the only 
groups that showed statistically significant increases in HYP 
content over time. The HYP content in the CS group at week 6 
was significantly higher than its corresponding values at weeks 
0 and 3, whereas the HYP content in the GRADIENT group at 
week 3 was significantly higher than its HYP content at week 0. In 
the normalized HYP (per DNA) content, the PLGA, CS, and the 
GRADIENT groups were statistically significantly higher than the 
CS group at week 3 (Figure 6B), with no significant differences 
occurring in the normalized HYP content among the PLGA, CS, 
and GRADIENT groups. The PLGA and TCP groups at week 3 
had statistically significantly higher normalized HYP content than 
their values at week 0 and 6, respectively. No significant differences 
were observed in the CS and GRADIENT groups over time in the 
normalized HYP content.
Calcium Content
The calcium content analysis revealed no significant differences 
between the PLGA and CS groups at week 0 (Figure 7A). The 
calcium contents of TCP and GRADIENT scaffolds at week 
0 are not reported because of insufficient sample size (n < 3), 
as some of the samples were lost during processing. At week 
3, the calcium content in the PLGA group was statistically 
significantly greater than the calcium contents in the CS, TCP, 
and GRADIENT groups. Also, the calcium contents in the CS 
and TCP groups at week 3 were statistically significantly higher 
than the calcium content in the GRADIENT group. At week 6, 
the calcium contents in the CS and GRADIENT groups were 
3.4- (p < 0.05) and 2.3-fold (p < 0.05) greater than the calcium 
content of the PLGA group. Moreover, the CS group calcium 
content at week 6 was observed to be statistically significantly 
higher than the calcium contents of the TCP and GRADIENT 
groups, and the GRADIENT group was found to be significantly 
higher than the TCP group in calcium content at week 6. No 
significant differences were observed in the calcium contents 
of the PLGA and TCP groups at that time, meaning that only 
the CS and GRADIENT groups outperformed the PLGA con-
trol in calcium content at week 6. The calcium content of the 
PLGA group increased statistically significantly at week 3 from 
its week 0 value, followed by a decrease at week 6 that was not 
statistically significant. The CS group had significantly higher 
calcium content at week 6 than at weeks 0 and 3. In addition, 
the GRADIENT group had significantly more calcium at week 6 
than at week 3. No significant differences in calcium content of 
the TCP group were observed over time. The normalized calcium 
Figure 6 | hYP content as measured in the microsphere-based 
scaffolds over weeks 0, 3, and 6. (a) Total HYP content in micrograms per 
construct. (B) Normalized HYP content in micrograms per micrograms DNA. 
All values are expressed as the average ± SD (n = 3–5), p < 0.05. 
@Statistically significant change over week 0 value, #statistically significant 
change over its value at previous time point, *statistically significant change 
over the PLGA group at same time point, &statistically significant change over 
the TCP group at same time point, and %statistically significant change over 
the CS group at same time point.
Figure 7 | calcium content as measured in the microsphere-based 
scaffolds over weeks 0, 3, and 6. Calcium content in the acellular 
constructs (TCP and GRADIENT groups) was subtracted from the calcium 
content in the corresponding cellular constructs. The calcium contents of the 
TCP and GRADIENT constructs at week 0 are not reported because of 
insufficient sample size (n < 3). (a) Total calcium content in micrograms per 
construct. (B) Normalized calcium content in micrograms per micrograms 
DNA. All values are expressed as the average ± SD (n = 3–5), p < 0.05. 
@Statistically significant change over week 0 value, #statistically significant 
change over its value at previous time point, *statistically significant change 
over the PLGA group at same time point, $statistically significant change over 
the TCP and GRADIENT groups at same time point, &statistically significant 
change over the TCP group at same time point, ^statistically significant 
change over the GRADIENT group at same time point, and %statistically 
significant change over the CS group at same time point.
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content (Figure 7B) of PLGA scaffolds at week 3 was statistically 
significantly higher than the normalized calcium contents in the 
CS, TCP, and GRADIENT groups. Additionally, the normalized 
calcium content in the TCP group at week 3 was statistically 
significantly higher than the normalized calcium contents of the 
CS and GRADIENT groups. Furthermore, at week 6, the PLGA 
group’s normalized calcium content was significantly higher than 
the normalized calcium content in the CS, TCP, and GRADIENT 
groups. The normalized calcium contents in the PLGA group 
at weeks 3 and 6 were statistically significantly higher than its 
corresponding value at week 0. However, the normalized calcium 
contents in the PLGA and TCP groups at week 6 were statistically 
significantly lower than their corresponding values at week 3. 
Again, it is to be emphasized that the values of calcium content 
are intended to represent the calcium present in the ECM secreted 
by the cells, and the calcium released from the microspheres and 
retained by the construct, and not the calcium still entrapped 
within the polymeric matrix.
ALP Activity
At week 0, the ALP activities in the TCP and GRADIENT groups 
were 2.2- (p < 0.05) and 2.5-fold (p < 0.05) higher than the ALP 
activity in the PLGA group (Figure 8). Moreover, the ALP activities 
in the TCP and GRADIENT groups at week 0 were statistically 
significantly higher than the ALP activity in the CS group. No 
significant differences were observed in the ALP activities of 
PLGA and CS groups at week 0, meaning that only the TCP and 
GRADIENT groups outperformed the PLGA control in ALP activ-
ity at that time point. No significant differences in ALP activity 
were observed over time in the PLGA and CS groups. However, it 
Figure 8 | alP activity in micromolar pnP released per micrograms 
Dna per minute. All values are expressed as the average ± SD (n = 3–5), 
p < 0.05. @Statistically significant change over week 0 value, *statistically 
significant change over the PLGA group at same time point, and %statistically 
significant change over the CS group at same time point.
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was observed that the ALP activities of the TCP and GRADIENT 
groups at week 0 were statistically significantly higher than their 
corresponding values at weeks 3 and 6.
gene expression
SOX9 and COL2A1
Relative SOX9 expression (Figure 9A) showed no significant 
differences among groups at week 0 and also no significant 
differences among the CS, TCP, and GRADIENT groups at week 
1.5. The SOX9 expression for PLGA group is not reported at 
week 1.5 due to insufficient sample size (n < 3 as some of the 
samples were lost during processing). The SOX9 expression for 
the PLGA group at week 3 was statistically significantly higher 
than the SOX9 expression of the CS, TCP, and GRADIENT 
groups. No significant differences among groups were observed 
in the SOX9 expression at week 6. The PLGA group was found 
to have statistically significantly higher SOX9 expression at 
week 3 than at weeks 0 and 6. No significant differences over 
time were observed in SOX9 expression within any of the other 
three groups.
The COL2A1 (collagen II) expression (Figure  9B) in the 
PLGA group followed a trend similar to SOX9 expression. No 
significant differences were observed in COL2A1 expression 
among the PLGA, CS, and GRADIENT groups at week 0 (the 
TCP group collagen II expression at week 0 is not reported due 
to insufficient sample size). The COL2A1 expression of the PLGA 
group at week 1.5 was statistically significantly higher than the 
COL2A1 expression of the CS and TCP groups. Additionally, 
the PLGA group had statistically significantly higher COL2A1 
expression than the CS, TCP, and the GRADIENT groups at 
week 3. The CS group at week 3 had significantly higher COL2A1 
expression than the TCP and GRADIENT groups. No significant 
differences in COL2A1 expression between the other two groups 
were observed at week 3. The CS group at week 6 outperformed 
the PLGA group in COL2A1 expression with 2.7-fold (p < 0.05) 
higher expression. Moreover, the CS group was statistically 
significantly higher in COL2A1 expression than the TCP and 
GRADIENT groups. No significant differences were observed in 
COL2A1 expression among the other three groups at that time, 
meaning that only the CS group outperformed the PLGA control 
group in COL2A1 expression at week 6. The COL2A1 expression 
in the PLGA and CS groups peaked at week 3 with statistically 
significant higher expression at week 3 than their respective 
values at earlier time points of weeks 0 and 1.5; however, the 
expression values in these groups decreased significantly at 
week 6 compared to their week 3 COL2A1 expression values. 
No significant differences over time were observed within the 
other two groups.
ACAN and COL1A1
No significant differences among groups were observed in the 
ACAN (aggrecan) expression at week 0 (Figure 9C). At week 
1.5, the ACAN expression in the GRADIENT group was 11.8-
fold (p <  0.05) higher than the PLGA group. Moreover, the 
ACAN expression in the GRADIENT group at week 1.5 was 
statistically significantly higher than the CS and TCP groups. No 
significant differences among other three groups were observed 
in the ACAN expression at that time, meaning that only the 
GRADIENT group outperformed the PLGA control group in 
ACAN expression at week 1.5. The ACAN expression of the CS 
group at week 3 was 10.5-fold (p < 0.05) higher than the PLGA 
group. In addition, the ACAN expression in the CS group at week 
1.5 was significantly higher than the expression levels in the TCP 
and GRADIENT groups. Only the CS group outperformed the 
PLGA group in ACAN expression at week 3, as no significant 
differences were observed in ACAN expression among the other 
three groups. At week 6, the TCP group alone outperformed the 
PLGA group in ACAN expression with a 3.3-fold (p <  0.05) 
higher expression. Moreover, the TCP group also had statistically 
significantly higher expression than the CS and GRADIENT 
groups at week 6. No significant differences were observed in 
ACAN expression over time in the PLGA group. The ACAN 
expression in the CS group at week 3 was statistically signifi-
cantly higher than the ACAN expression at the other three time 
points in the group. The TCP group had statistically significantly 
higher ACAN expression at week 6 than at weeks 0, 1.5, and 
3. Lastly, the GRADIENT group had statistically significantly 
higher ACAN expression at week 1.5 than ACAN expression at 
the other 3 weeks.
The COL1A1 (collagen I) expression (Figure  9D) of the 
GRADIENT at week 1.5 was 97-fold (p < 0.05) higher than the 
COL1A1 expression of the PLGA group, which was one of the 
only instances where a test group outperformed the PLGA control. 
In addition, the COL1A1 expression of the GRADIENT group 
was statistically significantly higher than the COL1A1 expres-
sion levels of the CS and TCP groups. No significant differences 
were observed in COL1A1 expression among groups at weeks 
0, 3, and 6. Additionally, the week 1.5 COL1A1 expression of 
the GRADIENT group was statistically significantly higher than 
its COL1A1 expression at any other time point. No significant 
differences were observed over time in any other group in the 
COL1A1 expression.
Figure 9 | relative gene expression. All values are expressed as the 
average ± SD (n = 3–5). (a) SOX9 expression: the PLGA group at week 1.5 is 
not reported because of insufficient sample size (n < 3). (B) COL2A1 
expression: the TCP group at week 0 is not reported because of insufficient 
sample size (n < 3). (c) ACAN expression. (D) COL1A1 expression. (e) RUNX2 
expression. (F) BGLAP expression: the PLGA value at week 1.5 is not reported 
because of insufficient sample size (n < 3). (g) SPP1 expression. (h) IBSP 
expression: the PLGA group at week 1.5 is not reported because of insufficient 
sample size (n < 3), p < 0.05. @Statistically significant change over 
week 0 value, #statistically significant change over its value at previous time 
point, *statistically significant change over the PLGA group at same time point, 
$statistically significant change over the TCP and GRADIENT groups at same 
time point, ?statistically significant change over week 1.5 value, %statistically 
significant change over the CS group at same time point, &statistically significant 
change over the TCP group at same time point, and ^statistically significant 
change over the GRADIENT group at same time point.
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RUNX2 and BGLAP
RUNX2 expression (Figure 9E) showed no significant differences 
among groups at week 0. However, at week 1.5, the PLGA and 
GRADIENT groups had statistically significantly higher RUNX2 
expression than the expression levels of the CS and TCP groups, 
but were not significantly different from each other. At week 3, 
the PLGA group had statistically significantly higher RUNX2 
expression than the other three groups. Moreover, the CS group 
at week 3 had significantly higher RUNX2 expression than the 
TCP group. Week 6 expression levels indicated that the TCP 
group had significantly higher RUNX2 expression than the CS 
and GRADIENT groups. The PLGA RUNX2 expression at week 
3 was found to be statistically significantly higher than its cor-
responding values at week 0 and week 6, but was not significantly 
different from its week 1.5 value. The GRADIENT group RUNX2 
expression at week 1.5 was statistically significantly higher than 
at its values at weeks 0 and 6, but did not differ significantly 
from its value at week 3. No significant differences over time 
were observed in the RUNX2 expression levels of the CS and 
TCP groups.
BGLAP expression (Figure 9F) showed no significant dif-
ferences among groups at week 0 and no significant differences 
among the CS, TCP, and GRADIENT groups at week 1.5 (PLGA 
value at week 1.5 is not reported because of insufficient sample 
size). At week 3, the CS group had 10.4-fold (p < 0.05) higher 
BGLAP expression than the PLGA group. Moreover, the CS 
group had statistically significantly higher BGLAP expression 
than the TCP and GRADIENT groups. At week 6, the PLGA 
group had statistically significantly higher BGLAP expression 
than the GRADIENT group. In addition, the CS group expres-
sion level was significantly higher than the expression levels 
of the TCP and GRADIENT groups. The CS group BGLAP 
expression at week 3 was statistically significantly higher 
than its values at weeks 0, 1.5, and 6, respectively. In addition, 
the CS group BGLAP expression at week 6 was statistically 
significantly higher than its values at weeks 0 and 1.5, but 
was significantly lower than its week 3 value. No significant 
differences over time were observed in the BGLAP expression 
within any other group.
SPP1 and IBSP
The SPP1 (osteopontin) expression (Figure  9G) showed no 
significant differences among groups at week 0. At week 1.5, the 
GRADIENT scaffolds had 248-fold (p < 0.05) higher SPP1 expres-
sion than the PLGA group, another example of gene expression in 
a test group outperforming the PLGA control. Moreover, the SPP1 
expression in the GRADIENT group was statistically significantly 
higher than the CS and TCP groups. No significant differences 
among the CS, TCP, and GRADIENT groups were observed in 
the SPP1 expression levels at week 3 (the PLGA group expression 
at week 3 is not reported due to insufficient sample size). Again, 
no significant differences among groups were observed at week 6. 
The CS group expression at week 3 was statistically significantly 
higher than at week 0. The GRADIENT group expression at week 
1.5 was significantly higher than at weeks 0, 3, and 6. No significant 
differences over time were observed within any of the remaining 
two groups.
IBSP expression (Figure 9H) showed no significant differences 
among the CS, TCP, and GRADIENT groups at week 1.5 (the 
values for CS, TCP, and GRADIENT groups at week 0; and the 
PLGA group at week 1.5 are not reported because of insufficient 
sample size). At week 3, the IBSP expression of the CS group was 
1.8-fold (p < 0.05) higher than the PLGA group. In addition, the 
CS group IBSP expression at week 3 was statistically significantly 
higher than the TCP and GRADIENT groups. The PLGA group 
at week 3 also had significantly higher expression than the TCP 
and GRADIENT groups. No significant differences among groups 
were observed at week 6. The CS group IBSP expression at week 
3 was statistically significantly higher than at weeks 1.5 and 6. No 
significant differences were observed over time within any of the 
other groups.
Discussion
The current study for the first time demonstrated the feasibility 
of raw material encapsulation in high molecular weight PLGA 
microsphere-based scaffolds that could potentially be used in 
large animal models or human patients. This work builds on 
our previous efforts that spoke of the advantages of raw material 
encapsulation (in conjunction with growth factors) toward creat-
ing a new tissue-specific ECM in low molecular weight PLGA 
scaffolds (Mohan et al., 2013). Furthermore, employing opposing 
gradients of CS and TCP to provide bioactive cues and building 
blocks for simultaneous chondrogenic and osteogenic differentia-
tion of cells is a promising approach for osteochondral interfacial 
tissue engineering. Additionally, to the best of our knowledge, 
we are the first group to encapsulate TCP in microsphere-based 
scaffolds for the bone part of our scaffolds. Most of the other groups 
utilizing microsphere-based scaffolds have relied on other calcium 
phosphates and minerals for engineering the bone tissue (Cushnie 
et al., 2008; Lv et al., 2009; Tahriri and Moztarzadeh, 2014; Xu 
et al., 2014).
The scanning electron microscopy (SEM) images, depicting the 
overall porous nature of microsphere-based scaffolds with inter-
connections among the pores, were in agreement with our previous 
findings with these scaffolds fabricated with low molecular weight 
PLGA (Singh et al., 2008). Moreover, raw material encapsulation 
did not affect the spherical nature of the microspheres; however, it 
was found to have altered the microstructure of the microspheres. 
Specifically, the CS microspheres had a porous surface that could be 
attributed to the solvent removal process during the microsphere 
fabrication step, as we have also observed previously (Mohan et al., 
2013). The presence of sub-micron pores on the CS microspheres 
contributed toward higher average porosity in these scaffolds 
compared to the other three groups. The TCP encapsulating 
microspheres, on the other hand, did not possess pores on their 
surfaces, but had a rough surface instead. The surface roughness of 
these microspheres, specifically the presence of ridge-like features, 
may have resulted from the partitioning of TCP particles on the 
surface of the microspheres. These surface characteristics of raw 
material encapsulating microspheres may have great implications 
in cell attachment or anchorage and also in diffusion of nutrients 
and wastes in and out of the scaffolds (Persson et al., 2014; Wu 
et al., 2014). Furthermore, raw material encapsulation impacted 
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the cellular morphology of the seeded rBMSCs. Flat cells with 
significant cell spreading were observed in the CS and GRADIENT 
groups while cluster forming round cells could be seen in the TCP 
and GRAIDENT groups. Though the GRADIENT group contained 
both flat and round cells, no differences in cell morphologies were 
observed in cells from distinct regions of the scaffold. The different 
cell morphologies on microsphere-based scaffolds might suggest 
that cells responded favorably to the encapsulated raw materials, at 
least initially, which may have influenced their differentiation along 
discrete pathways. This initial cellular response to encapsulated raw 
materials could have pivotal significance in regenerating interfacial 
tissues that require differentiation of cells from a single source 
along multiple pathways.
Mechanical testing results demonstrated the compressive 
moduli of microsphere-based scaffolds to be in the range of 
articular cartilage (0.1–0.9 MPa) and within an order of magnitude 
of the moduli for cancellous bone (0.01–2  GPa) (Keaveny and 
Hayes, 1993; Mansour, 2003; Williams et al., 2003). Moreover, the 
elastic modulus of TCP scaffolds at week 0 was found to be at least 
three times as large as any other group, thereby conforming to the 
observations of Lv et al. demonstrating that calcium phosphates 
enhance the mechanical properties of polymeric scaffolds (Lv 
et al., 2009). However, at week 6, the cell seeded TCP constructs 
had significantly higher modulus than the CS group alone. All 
the other groups, except for the CS group, had an increase in 
their elastic moduli from week 0. Differences among groups in 
degradation rates of the scaffolds, cell proliferation within the 
scaffolds, and ECM deposition could have all contributed to the 
increase in moduli. PLGA microspheres are known to degrade via 
bulk erosion where the rate-limiting step is the diffusion of water 
molecules into the microsphere core. CS microspheres because 
of their porous nature may have allowed faster diffusion of the 
water molecules into their core, thereby initiating the polymer 
degradation more quickly than in the other three groups. Higher 
glycolic acid content in PLGA (PLGA50:50) of CS microspheres 
may have further accelerated polymer degradation in the CS group 
(Alexis, 2004). Additionally, swelling (Table S3 in Supplementary 
Material) caused by penetration of water inside of the microspheres 
may have also played a part in the drop in elastic modulus of CS 
scaffolds (Mohan et al., 2013). On the other hand, swelling was 
absent (PLGA and TCP groups) or less pronounced (GRADIENT 
group) in the other three groups compared to the CS group, which 
may have prevented the drop in elastic moduli of scaffolds from 
the PLGA, TCP, and GRADIENT groups at week 6. Moreover, 
polymer composition (PLGA75:25) and microsphere morphology 
(absence of minute pores on surface) may have allowed the PLGA, 
TCP, and GRADIENT scaffolds to further retain their mechanical 
properties. Surprisingly, the PLGA scaffolds had a tremendous 
increase in modulus from week 0 to week 6, translating to an 
elastic modulus orders of magnitude higher than the moduli 
of the other three groups at week 6. We previously observed a 
similar trend in elastic moduli in raw material encapsulating 
low molecular weight PLGA scaffolds where deviations from the 
overall scaffold structure at week 6 led to a significant increase 
in elastic modulus (Mohan et al., 2013). Additionally, the elastic 
moduli of high molecular weight PLGA acellular scaffolds at week 
6 (unpublished data) also hinted toward a similar phenomenon. 
Therefore, it is speculated that cellular contributions, in conjunc-
tion with polymer degradation, led to microscopic changes in 
the scaffold morphology (closure of pores) that caused the elastic 
moduli of PLGA constructs to jump at week 6. However, further 
investigation is needed to better understand the degradation in 
these high molecular weight PLGA scaffolds and the mechanism 
of increase in their compressive moduli with time. Altogether, 
results from the mechanical testing provided information that 
would be valuable in designing microsphere-based scaffolds for 
future in vitro and in vivo studies in rabbits, sheep, etc.
The biochemical content results were found to be consistent 
with the SEM observations. A small number of cells were observed 
on the PLGA scaffolds at Day 10, which agreed with the DNA 
content analysis that revealed low quantities of DNA on these scaf-
folds throughout the 6-week culture period. By contrast, the DNA 
contents of all the raw material encapsulating groups increased over 
time with significant differences appearing at week 6. Our DNA 
results on microsphere-based scaffolds suggest that raw material 
encapsulation encouraged rBMSC proliferation on these scaffolds, 
thus agreeing with the findings of some other groups showing 
that the raw materials such as CS and β-TCP could cast a positive 
influence on the proliferative capacity of rBMSCs (Takahashi 
et al., 2005; Uygun et al., 2009; Todo and Arahira, 2013; Kim et al., 
2014). GAG data showed that the CS group had at least a threefold 
higher GAG content than the rest of the groups at week 6. Since the 
GAG content of acellular constructs (Table S1 in Supplementary 
Material) was subtracted at each time point, it is to be stressed that 
the data primarily represented GAG secreted by the cells and also 
released CS entrapped within the newly synthesized ECM. A trend 
similar to GAG content was seen in the HYP content of CS scaffolds 
suggesting that the encapsulated CS played a significant role in 
enhancing the cellular GAG and collagen secretion, thus having 
a modulatory effect on the seeded rBMSCs. However, observance 
of lower normalized GAG and HYP content in the CS group than 
the PLGA group suggest that the bioactive effects seen due to CS 
encapsulation may have been primarily due to the improvement 
in cellularity without sacrificing biosynthesis on a per cell basis. 
Calcium content analysis revealed some unanticipated results. The 
CS group had significantly higher net calcium content than the 
other groups at week 6, and the PLGA group was higher in calcium 
per DNA content compared to rest of the groups at that time. The 
counter-intuitive phenomenon of high calcium (or calcium per 
DNA) contents in the CS and PLGA groups could be attributed 
to culture medium components, such as DEX, β-GP, and IGF-I. 
DEX is a glucocorticoid, which is used extensively in vitro as an 
osteogenic factor. β-GP is the common source for MSCs to form 
CaP deposits in  vitro (Shi et  al., 2010; Fiorentini et  al., 2011). 
IGF-I is an anabolic signal that does not necessarily influence the 
proliferation and differentiation of MSCs toward osteoblasts on its 
own, but it is an important molecule directing the differentiation 
of already osteogenically committed cells (Hayrapetyan et  al., 
2014). Thus, the presence of these components likely influenced 
the commitment of rBMSCs on the microsphere-based scaffolds 
toward osteogenesis. Furthermore, the ALP activities of the TCP 
and GRADIENT groups at week 0 were higher than their activi-
ties at week 6. The elevated ALP activities in these constructs at 
earlier time points may have been due to the medium components. 
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However, failure to observe a similar effect in the other two groups 
hint that TCP encapsulation might have influenced their behavior 
initially as seen with the SEM micrographs as well. Lastly, higher 
normalized HYP and calcium contents in the TCP encapsulating 
scaffold groups than the CS group at later time points suggest 
that TCP encapsulation may have improved rBMSC performance 
by promoting their differentiation in addition to enhancing their 
proliferation (as seen with DNA content results).
Gene expression results were in agreement with the other results 
of the study. Relatively higher expressions of SOX9, COL2A1, and 
RUNX2 by the cells in the PLGA group at week 3 followed by 
higher mineral content at week 6 (as indicated by the biochemical 
data) suggest that the DEX in culture the medium may have caused 
the rBMSCs in the PLGA scaffolds to go down the osteogenic path-
way via a cartilage-like intermediate. Higher expression levels of 
chondrogenic markers (collagen II and aggrecan), in conjunction 
with up regulation of osteogenic markers (BGLAP and IBSP) by the 
cells in the CS group at week 3 than compared to the initial time 
points, suggest a similar phenomenon as observed in the PLGA 
group. Lower expression of BGLAP and IBSP in the TCP group 
than the CS group suggests that TCP presence inhibited expression 
of osteogenic markers by creating a substrate environment that 
was already high in mineral content, a phenomenon previously 
observed with hydroxyapatite encapsulating low molecular weight 
PLGA microsphere-based scaffolds (Dormer et al., 2012a). The 
cells in the GRADIENT group showed relatively higher expres-
sion of ACAN and SPP1 (along with higher expression of RUNX2 
by the cells in the group than at week 0) than the cells in the 
PLGA control group at week 1.5. The higher expression of some 
chondrogenic and osteogenic markers in the GRADIENT group 
at earlier time points may be due to faster maturation of rBMSCs 
toward cartilage- and bone-like cells in this group; however, more 
evidence is needed to reinforce this speculation.
Overall, the results of the current study indicate that raw mate-
rial encapsulation into microsphere-based scaffolds influenced the 
behavior of the seeded rBMSCs. Differences in the cell morpholo-
gies and greater cell numbers in the raw material groups leading 
to enhanced matrix synthesis in these groups demonstrates that 
the raw materials provide a head start in the (re)generation of 
tissues. It is of interest to infer the amount of matrix synthesized 
by cells in the scaffolds beyond the exogenously included amounts. 
Therefore, the biochemical content (CS and calcium) for the 
acellular constructs was subtracted from the content of the cell 
seeded constructs, assuming that the acellular scaffolds degrade 
and release encapsulated molecules at the same rate as their cellular 
counterparts. However, we acknowledge that this assumption is 
weak as cells synthesizing new matrix, and perhaps altering the sur-
rounding pH, etc., will influence the polymer degradation rate, but 
with the higher molecular weight PLGA, it should be a reasonable 
approximation that allows us to better evaluate differences among 
groups due to cellular contribution. In addition, static seeding 
approach employed in this study has limitations associated with it 
due to the manual- and operator-dependent nature of the process. 
However, we followed a uniform manual seeding procedure, and 
we think that the differences observed in the DNA content at week 
0 (24  h post seeding) among various scaffold type might have 
resulted more from the differences in cell attachment arising due 
to differences in scaffold composition than arising from variations 
in cell seeding. Moreover, we did not specifically explore the dosing 
effect of CS and TCP, but our group has demonstrated in the past 
that the concentration of the raw materials can have a significant 
effect on the differentiation of the cells (Dormer et al., 2012a). 
Additionally, higher cell number, greater biochemical content, and 
relatively higher expression of some osteogenic and chondrogenic 
markers in the GRADIENT group accentuated the advantages of 
using gradient-based strategies for engineering the osteochondral 
interface. However, we recognize that these scaffolds not being 
amenable to histology due to the stiffness of the polymer con-
structs, given the high molecular weight and slow degradation of 
the PLGA, was a limitation of the study that would have further 
elaborated the differences among groups based on their regional 
material composition, but we have substantiated previously both 
in vitro and in vivo that regionalized tissue formation occurs in 
raw material gradient microsphere-based engineered constructs 
(Mohan et  al., 2011, 2013). Furthermore, the initial effects of 
raw material encapsulation on a per-cell basis might have been 
obscured by the culture medium components that appeared to 
favor osteogenesis. However, it is to be noted that in vitro advance-
ments observed initially with raw material encapsulation could 
translate in vivo to a more favorable interaction with infiltrating 
MSCs, and perhaps facilitate differentiation in a native environ-
ment rather than in a medium-governed environment. Lastly, an 
important consideration in designing scaffolds for clinical use 
is determining the mechanical integrity. We have shown in our 
prior work that microsphere-based scaffolds possess adequate 
mechanical properties for the regeneration of osteochondral 
tissues and the encapsulation of raw materials may impact those 
properties (Dormer et al., 2010, 2012a; Mohan et al., 2013). Our 
mechanical testing results in the current study also agreed with 
our previous findings; additionally, the results also suggested that 
the mechanical properties of microsphere-based scaffolds can be 
impacted by scaffold degradation and cellular matrix synthesized 
by the seeded cells. Additional cyclic testing in the future may yield 
interesting information about degree of hysteresis and narrower 
strain ranges about a fixed strain point (e.g., 5%), with a frequency 
sweep could yield interesting tan delta profiles as well, which we 
will consider for future studies.
Altogether, the overall findings emphasize the need to further 
refine the technology, perhaps by adjusting raw material concen-
tration or by altering PLGA degradation rate. The degradation 
of the polymer will play a key role in tissue regeneration in vivo, 
where premature failure in scaffold mechanical properties can 
have a deleterious effect on the regenerating tissue, and extended 
degradation by contrast could become an obstacle to tissue regen-
eration. Therefore, it is important to identify a polymer with a 
biodegradation rate comparable to the neo-tissue formation rate. 
Additionally, identifying raw material concentrations that are 
most efficacious in promoting osteogenesis and chondrogenesis 
would yield valuable information, which could then be leveraged 
for tailoring scaffold degradation in future sheep or any other 
large animal model studies. Nevertheless, the current study 
highlights several benefits of raw material microsphere gradient 
scaffold technology. The raw material encapsulating microsphere-
based scaffolds attempt to regenerate both cartilage and bone 
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simultaneously, thus stressing on the importance of growing 
cartilage and bone within the physical proximity of each other; 
many signaling pathways and endogenous proteins responsible 
for progenitor cell commitment to the osteoblast or chondrocyte 
lineages have a high degree of interrelatedness (Gordeladze et al., 
2009). The raw materials apart from being conductive to tissue (re)
generation can also provide inductive signals to the surrounding 
cells guiding their differentiation. In addition, the raw materials 
provide clinical significance to microsphere gradient scaffolds, as 
these scaffolds may be tactically placed for swifter and less costly 
regulatory approval.
conclusion
The present study assessed the in vitro response of microsphere-
based scaffolds with clinical relevance fabricated using a raw 
material approach. Overall, the results demonstrated that the 
primary improvements observed with the raw materials-CS and 
TCP were more due to greater initial interaction with cells and 
greater cellularity with comparable performance on a per-cell basis 
rather than on specifically driving differentiation. Moreover, the 
medium-governed environment that seemed to favor osteogenesis 
concealed the initial in  vitro advancements observed with raw 
material encapsulation. Additionally, there was also evidence of 
faster maturation of rBMSCs in the raw material GRADIENT 
constructs that can be leveraged further to engineer the complex 
osteochondral interface. Therefore, a strategy combining the 
“building block” side of the raw material philosophy (as we have 
done here) with the “signaling” side, for example, by including 
hydroxyapatite with the TCP, or maybe TGF-β with CS, or by 
altering the dose of CS (without TGF-β); in a scaffold with a bio-
degradation rate comparable to the neo-tissue formation rate, we 
may be able to achieve the differentiation profiles we seek in vitro.
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